0001709401-22-000004.txt : 20220801
0001709401-22-000004.hdr.sgml : 20220801
20220801173845
ACCESSION NUMBER: 0001709401-22-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220729
FILED AS OF DATE: 20220801
DATE AS OF CHANGE: 20220801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schaffert Susanne
CENTRAL INDEX KEY: 0001938363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 221126032
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS, INC.
STREET 2: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_165938990864068.xml
FORM 4
X0306
4
2022-07-29
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001938363
Schaffert Susanne
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
0.702
2022-07-29
4
A
0
50000
0
A
2032-07-28
Common Stock
50000.0
50000
D
This option shall vest in equal quarterly installments over the twelve quarters following the grant date.
/s/ Maiken Keson-Brookes, as Attorney-in-Fact
2022-08-01